Tessa Romero Analyst PerformanceSenior Analyst - Biotechnology Equity Research at JPMorgan Chase & Co.Tessa Romero is a stock analyst at JPMorgan Chase & Co. in the healthcare sector, covering 16 publicly traded companies. Over the past year, Tessa Romero has issued 33 stock ratings, including buy, hold, and sell recommendations. While full access to Tessa Romero's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Tessa Romero's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings41 Last 1 YearsBuy Recommendations70.73% 29 Buy RatingsCompanies Covered16 Unique Companies Ratings Distribution41RatingsDistribution of strong buy, buy, hold, and sell ratings by Tessa Romero.RatingPercentageCount Strong Buy0.0%0 ratings Buy70.7%29 ratings Hold24.4%10 ratings Sell4.9%2 ratingsOut of 41 total stock ratings issued by Tessa Romero at JPMorgan Chase & Co., the majority (70.7%) have been Buy recommendations, followed by 24.4% Hold and 4.9% Sell.Best & Worst CallsBest Call0000.0%CYTKJun 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%BHVNMar 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ93.8% of companies on NASDAQ15 companiesNYSE6.3% of companies on NYSE1 companyTessa Romero, an analyst at JPMorgan Chase & Co., currently covers 16 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare16 companies100.0%Tessa Romero of JPMorgan Chase & Co. specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageBIOTECHNOLOGY12 companies75.0%PHARMACEUTICALS4 companies25.0% Tessa Romero's Ratings History at JPMorgan Chase & Co. Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsAGIOAgios Pharmaceuticals8/7/2026Boost Price Target$31.74$34.00Neutral$0.0000.00% ROILXEOLexeo Therapeutics6/25/2026Lower Price Target$4.81$9.00Overweight$0.0000.00% ROIUPBUpstream Bio6/12/2026Downgrade$6.38$8.00Neutral$0.0000.00% ROIAGIOAgios Pharmaceuticals6/11/2026Lower Price Target$28.82$31.00Neutral$0.0000.00% ROIOCSOculis6/3/2026Lower Price Target$12.66$23.00Overweight$0.0000.00% ROIXENEXenon Pharmaceuticals5/27/2026Boost Price Target$54.22$82.00Overweight$0.0000.00% ROILRMRLarimar Therapeutics5/27/2026Initiated Coverage$3.59$9.00Overweight$0.0000.00% ROISPTXSeaport Therapeutics5/26/2026Initiated Coverage$17.50$42.00Overweight$0.0000.00% ROIOCSOculis5/18/2026Boost Price Target$28.94$42.00Overweight$0.0000.00% ROICYTKCytokinetics5/12/2026Boost Price Target$74.56$97.00Overweight$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. XENEXenon Pharmaceuticals5/12/2026Boost Price Target$55.14$80.00Overweight$0.0000.00% ROIAGIOAgios Pharmaceuticals4/6/2026Boost Price Target$34.86$36.00Neutral$0.0000.00% ROISEPNSepterna3/24/2026Boost Price Target$23.35$38.00Overweight$0.0000.00% ROIEWTXEdgewise Therapeutics3/17/2026Boost Price Target$30.95$45.00Overweight$0.0000.00% ROICYTKCytokinetics3/17/2026Boost Price Target$62.29$75.00Overweight$0.0000.00% ROISRRKScholar Rock3/16/2026Boost Price Target$40.79$50.00Overweight$0.0000.00% ROIACADACADIA Pharmaceuticals3/4/2026Boost Price Target$23.25$34.00Overweight$0.0000.00% ROIDYNDyne Therapeutics1/20/2026Lower Price Target$16.39$16.00Neutral$0.0000.00% ROICYTKCytokinetics1/20/2026Boost Price Target$62.85$74.00Overweight$0.0000.00% ROIXENEXenon Pharmaceuticals1/9/2026Boost Price Target$41.22$62.00Overweight$0.0000.00% ROIAGIOAgios Pharmaceuticals1/6/2026Boost Price Target$27.43$25.00Neutral$0.0000.00% ROIOCSOculis12/19/2025Initiated Coverage$19.48$38.00Overweight$0.0000.00% ROIAGIOAgios Pharmaceuticals11/21/2025Lower Price Target$24.67$20.00Neutral$0.0000.00% ROIBHVNBiohaven11/20/2025Lower Price Target$9.55$15.00Overweight$0.0000.00% ROIRCKTRocket Pharmaceuticals11/18/2025Downgrade$2.98Underweight$0.0000.00% ROIXENEXenon Pharmaceuticals11/18/2025Boost Price Target$40.32$60.00Overweight$0.0000.00% ROISRRKScholar Rock11/18/2025Boost Price Target$38.71$47.00Overweight$0.0000.00% ROIACADACADIA Pharmaceuticals11/17/2025Lower Price Target$24.45$31.00Overweight$0.0000.00% ROIDYNDyne Therapeutics11/14/2025Lower Price Target$18.86$17.00Neutral$0.0000.00% ROIEWTXEdgewise Therapeutics11/14/2025Boost Price Target$23.00$34.00Overweight$0.0000.00% ROIACADACADIA Pharmaceuticals9/29/2025Lower Price Target$21.05$33.00Overweight$0.0000.00% ROINMRANeumora Therapeutics9/16/2025Downgrade$1.52Underweight$0.0000.00% ROIEWTXEdgewise Therapeutics8/19/2025Lower Price Target$13.83$30.00Overweight$0.0000.00% ROIACADACADIA Pharmaceuticals7/24/2025Boost Price Target$23.16$34.00Overweight$00.0000.00% ROIDYNDyne Therapeutics7/15/2025Lower Price Target$8.35$9.00Neutral$00.0000.00% ROIBHVNBiohaven6/18/2025Lower Price Target$14.58$55.00Overweight$00.0000.00% ROICYTKCytokinetics6/9/2025Lower Price Target$32.65$53.00Overweight$00.0000.00% ROIACADACADIA Pharmaceuticals6/6/2025Boost Price Target$22.05$30.00Overweight$00.0000.00% ROILXEOLexeo Therapeutics5/30/2025Lower Price Target$2.76$10.00Overweight$0.0000.00% ROIDYNDyne Therapeutics3/21/2025Lower Price Target$12.18$17.00Neutral$00.0000.00% ROIALERT: Drop these 5 stocks before the market opens tomorrow! (Ad)The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.See the 5 stocks to avoidBHVNBiohaven3/5/2025Lower Price Target$30.90$68.00Overweight$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital Markets Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
